Veerhealth Care (BSE:511523) - Share price, News & Analysis

511523 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

511523 Stock Overview

Veerhealth Care Limited engages in the manufacturing, marketing, and trading of ayurvedic medicines in India.

Rewards

Trading at 77.4% below our estimate of its fair value

Became profitable this year

Risk Analysis

Earnings have declined by 8.3% per year over past 5 years

Does not have a meaningful market cap (₹88M)

Does not have meaningful revenue (₹107M)

Price History & Performance

Summary of all time highs, changes and price drops for Veerhealth Care
Historical stock prices
Current Share Price	₹12.75
52 Week High	₹18.98
52 Week Low	₹8.20
Beta	0.82
1 Month Change	5.81%
3 Month Change	15.07%
1 Year Change	24.76%
3 Year Change	61.39%
5 Year Change	-2.15%
Change since IPO	632.76%

Shareholder Returns

	511523	IN Pharmaceuticals	IN Market
7D	-1.9%	-4.3%	-4.5%
1Y	24.8%	-8.1%	15.1%

Return vs Industry: 511523 exceeded the Indian Pharmaceuticals industry which returned -8.1% over the past year.

Return vs Market: 511523 exceeded the Indian Market which returned 15.1% over the past year.

Price Volatility

Is 511523's price volatile compared to industry and market?
511523 volatility
511523 Average Weekly Movement	7.4%
Pharmaceuticals Industry Average Movement	6.9%
Market Average Movement	7.2%
10% most volatile stocks in IN Market	10.0%
10% least volatile stocks in IN Market	4.7%

Stable Share Price: 511523 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 511523's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1992	15	Bhavin Shah	https://veerhealthcare.net

Veerhealth Care Limited engages in the manufacturing, marketing, and trading of ayurvedic medicines in India. The company offers skincare products, such as creams, lip balms, moisturizing lotions, face packs, rosewater, and scrubs; body care products, including bodywash, facewash, handwash, and soaps; hair oils, shampoos, and conditioners; body mist fragrances; pain relief oils, tablets, syrups, and sanitizers; toothpaste; gifting products; and other accessories. It also exports its products.

Veerhealth Care Fundamentals Summary

How do Veerhealth Care's earnings and revenue compare to its market cap?
511523 fundamental statistics
Market Cap	₹88.41m
Earnings (TTM)	₹501.00k
Revenue (TTM)	₹107.39m

176.5x

P/E Ratio

0.8x

P/S Ratio

Is 511523 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
511523 income statement (TTM)
Revenue	₹107.39m
Cost of Revenue	₹69.40m
Gross Profit	₹37.99m
Other Expenses	₹37.49m
Earnings	₹501.00k

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	0.072
Gross Margin	35.37%
Net Profit Margin	0.47%
Debt/Equity Ratio	0.0%

How did 511523 perform over the long term?

See historical performance and comparison

Valuation

Is Veerhealth Care undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 511523 (₹12.75) is trading below our estimate of fair value (₹56.33)

Significantly Below Fair Value: 511523 is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: 511523 is poor value based on its PE Ratio (176.5x) compared to the Indian Pharmaceuticals industry average (22.8x).

PE vs Market: 511523 is poor value based on its PE Ratio (176.5x) compared to the Indian market (20.9x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 511523's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: 511523 is good value based on its PB Ratio (0.6x) compared to the IN Pharmaceuticals industry average (2.8x).

Future Growth

How is Veerhealth Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

20.3%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Veerhealth Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Veerhealth Care performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

-8.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 511523 has high quality earnings.

Growing Profit Margin: 511523 became profitable in the past.

Past Earnings Growth Analysis

Earnings Trend: 511523's earnings have declined by 8.3% per year over the past 5 years.

Accelerating Growth: 511523 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 511523 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (14.6%).

Return on Equity

High ROE: 511523's Return on Equity (0.4%) is considered low.

Financial Health

How is Veerhealth Care's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: 511523's short term assets (₹62.3M) exceed its short term liabilities (₹9.4M).

Long Term Liabilities: 511523's short term assets (₹62.3M) exceed its long term liabilities (₹36.3M).

Debt to Equity History and Analysis

Debt Level: 511523 is debt free.

Reducing Debt: 511523 has no debt compared to 5 years ago when its debt to equity ratio was 6.9%.

Debt Coverage: 511523 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 511523 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Dividend

What is Veerhealth Care current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 511523's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 511523's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 511523's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 511523's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 511523 has not reported any payouts.

Next Steps

Explore strong dividend paying companies in the Pharmaceuticals & Biotech industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

9.0yrs

Average board tenure

CEO

Bhavin Shah (40 yo)

9yrs

Tenure

₹960,000

Compensation

Mr. Bhavin Satish Shah serves as Non-Executive Director at Veer Energy & Infrastructure Limited. Mr. Shah has been Managing Director at Veerhealth Care Limited since May 22, 2013 and its Whole Time Directo...

CEO Compensation Analysis

Compensation vs Market: Bhavin's total compensation ($USD12.48K) is below average for companies of similar size in the Indian market ($USD39.20K).

Compensation vs Earnings: Bhavin's compensation has been consistent with company performance over the past year.

Board Members

Experienced Board: 511523's board of directors are considered experienced (9 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/07 00:00
End of Day Share Price	2022/05/06 00:00
Earnings	2021/12/31
Annual Earnings	2021/03/31